Adjunctive nabilone in cancer pain and symptom management: A prospective observational study using propensity scoring

Journal of Supportive Oncology

Volumn 6, Issue 3, 2008, Pages 119-124

  Maida, Vincent ^a,b,c,d   Ennis, Marguerite ^a,b,c,d   Irani, Shiraz ^a,b,c,d   Corbo, Mario ^a,b,c,d   Dolzhykov, Michael ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Hope Health Care ^*  (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GABAPENTIN; METOCLOPRAMIDE; NABILONE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; TRICYCLIC ANTIDEPRESSANT AGENT;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANOREXIA; ANXIETY; ARTICLE; BEDTIME DOSAGE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSPNEA; EDMONTON SYMPTOM ASSESSMENT SYSTEM; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; XEROSTOMIA;

ADJUVANTS, PHARMACEUTIC; AGED; AGED, 80 AND OVER; ANALGESICS; ANTI-ANXIETY AGENTS; ANTIEMETICS; CANCER CARE FACILITIES; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASMS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; PROSPECTIVE STUDIES; TETRAHYDROCANNABINOL; TREATMENT OUTCOME;

EID: 41549099679     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 2007;15:1407-1412.
2. Wilson KG, Chochinov HM, McPherson CJ, et al. Suffering with advanced cancer. J Clin Oncol 2007;25:1691-1697.
3. Vaz AF, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Esteves SB. Quality of life of women with gynecologic cancer: associated factors. Arch Gynecol Obstet 2007;276:583-589.
4. Davis M, Maida V, Daeninck P, Pergolizzi J. The emerging role of cannabinoid neuromodulators in symptom management. Support Care Cancer 2007;15:63-71.
5. Mack A, Joy J. Marijuana as Medicine: The Science Beyond the Controversy. Washington, DC: Institute of Medicine, National Academy Press; 2000.
6. Kalant H. Medicinal use of cannabis: history and current status. Pain Res Manage 2001;6:80-91.
7. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-613.
8. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990;346:561-564.
9. Ben Amar M. Cannabinoids in medicine:a review of their therapeutic potential. J Ethnopharmacol 2006;105:1-25.
10. Aguado T, Carracedo A, Julien B, et al. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem 2007;282:6854-6862.
11. Aguado T, Palazuelos J, Monory K, et al. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 2006;26:1551-1561.
12. Xu X, Liu Y, Huang S, et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 2006;171:31-38.
13. Blázquez C, Carracedo A, Barrado L, et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006; 20:2633-2635.
14. Sargaraz S, Afaq F, Adhami VM, Mukhtar H. Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 2005;65:1635-1641.
15. Steinhauser KE, Clipp EC, Hays JC, et al. Identifying, recruiting, and retaining seriously-ill patients and their caregivers in longitudinal research. Palliat Med 2006;20:745-754.
16. McWhinney IR, Bass MJ, Donner A. Evaluation of a palliative care service:problems and pitfalls. BMJ 1994;309:1340-1342.
17. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36:621-626.
18. Buss MK, Arnold RM. Challenges in palliative care research: one experience. J Palliat Med 2004;7:405-407.
19. Change VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88:2164-2171.
20. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS):a new tool. J Palliat Care 1996;12:5-11.
21. Head B, Ritchie CS, Smoot TM. Prognostication in hospice care: can the palliative performance scale help? J Palliat Med 2005;8:492-502.
22. Doyle D, Hanks G, Cherney N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd ed. USA: Oxford University Press; 2005:319-320.
23. Klungel OH, Martens EP, Psaty BM, et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol 2004;57:1223-1231.
24. Esper P, Heidrich D. Symptom clusters in advance illness. Semin Oncol Nurs 2005;21:20-28.
25. Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 2004;31:202-212.
26. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000;8:175-179.
27. Chen ML, Tseng HC. Symptom clusters in cancer patients. Support Care Cancer 2006;14:825-830.
28. Abrahm JL. A Physician's Guide to Pain and Symptom Management in Cancer Patients. 2nd ed. Baltimore, Md: The Johns Hopkins University Press; 2004.
29. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 2004;11:354-365.
30. Sacerdote P, Manfredi B, Mantegazza P, Panerai AE. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol 1997;121:834-840.
31. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002;20:3992-3998.
32. Krzyzanawska MK, Weeks JC, Earle CC. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol 2003;21:3409-3414.
33. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001;19:1064-1070.